How Many Human Immunodeficiency Virus Type 1-Infected Target Cells Can a Cytotoxic T-Lymphocyte Kill?

ABSTRACT The antiviral role of CD8+ cytotoxic T lymphocytes (CTLs) in human immunodeficiency virus type 1 (HIV-1) infection is poorly understood. Specifically, the degree to which CTLs reduce viral replication by killing HIV-1-infected cells in vivo is not known. Here we employ mathematical models of the infection process and CTL action to estimate the rate that CTLs can kill HIV-1-infected cells from in vitro and in vivo data. Our estimates, which are surprisingly consistent considering the disparities between the two experimental systems, demonstrate that on average CTLs can kill from 0.7 to 3 infected target cells per day, with the variability in this figure due to epitope specificity or other factors. These results are compatible with the observed decline in viremia after primary infection being primarily a consequence of CTL activity and have interesting implications for vaccine design.

[1]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[2]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[3]  Hulin Wu,et al.  Deterministic And Stochastic Models Of Aids Epidemics And Hiv Infections With Intervention , 2005 .

[4]  Rob J. De Boer,et al.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation , 1998, Nature Medicine.

[5]  J. Sprent,et al.  Lifespan of lymphocytes , 1995, Immunologic research.

[6]  O. Yang,et al.  Impacts of Epitope Expression Kinetics and Class I Downregulation on the Antiviral Activity of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes , 2004, Journal of Virology.

[7]  S. Riddell,et al.  Nonmyeloablative Immunosuppressive Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells in a Nonhuman Primate Model , 2001, Journal of Virology.

[8]  S. Self,et al.  Do scarce targets or T killers control primary HIV infection? , 2002, Journal of theoretical biology.

[9]  Susan M. Kaech,et al.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.

[10]  B. Walker,et al.  Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL 1 , 2003, The Journal of Immunology.

[11]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[12]  William H. Press,et al.  Numerical recipes in C , 2002 .

[13]  Alan S. Perelson,et al.  Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen , 1998, The Journal of experimental medicine.

[14]  S. Self,et al.  On simulating strongly interacting, stochastic population models. II. Multiple compartments. , 2004, Mathematical biosciences.

[15]  S. Self,et al.  What's the matter with HIV-directed killer T cells? , 2002, Journal of theoretical biology.

[16]  M. Baalen,et al.  Impact of antigen expression kinetics on the effectiveness of HIV‐specific cytotoxic T lymphocytes , 2002, European journal of immunology.

[17]  D Wick,et al.  Early HIV infection in vivo: branching-process model for studying timing of immune responses and drug therapy. , 2000, Mathematical biosciences.

[18]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[19]  R P Johnson,et al.  Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes , 1996, Journal of virology.

[20]  B. Walker,et al.  Techniques in HIV Research , 1990, Palgrave Macmillan UK.

[21]  S. Riddell,et al.  The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. , 1999, Journal of immunology.

[22]  D Wick,et al.  On T-cell dynamics and the hyperactivation theory of AIDS pathogenesis. , 1999, Mathematical biosciences.

[23]  Alan S. Perelson,et al.  Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.

[24]  D. Montefiori,et al.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.

[25]  J. Schmitz,et al.  Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. , 1999, Journal of immunology.

[26]  A. McLean,et al.  In vivo estimates of division and death rates of human T lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R P Johnson,et al.  Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.

[28]  R. Young,et al.  Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Nancy Haigwood,et al.  Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasma , 1999, Nature Medicine.

[30]  L. Weinberger,et al.  Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.

[31]  H. Grosse-wilde,et al.  Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. , 1996, Blood.

[32]  R Blumenthal,et al.  Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.

[33]  Galit Alter,et al.  Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells , 2004, The Journal of experimental medicine.

[34]  Alessandro Sette,et al.  Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.

[35]  S. Riddell,et al.  HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. , 2000, The Journal of clinical investigation.

[36]  M. Ascher,et al.  AIDS as immune system activation: a model for pathogenesis. , 1988, Clinical and experimental immunology.

[37]  H. Clifford Lane,et al.  Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques , 1998, Journal of Virology.

[38]  A. B. Lyons,et al.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.